Showing 15 posts of 103 posts found.


Abbott to acquire Bigfoot Biomedical

September 6, 2023
Business Services Abbott, Bigfoot Biomedical, Diabetes, acquisition, diabetes

Abbott and Bigfoot Biomedical have announced a definitive agreement for Abbott to acquire Bigfoot, however this transaction is still subject …

FDA approves Abbott’s Assert-IQ insertable cardiac monitor

May 19, 2023
Research and Development Abbott, Cardiology, Devices, FDA, heart monitor, medical devices

Abbott has announced that the US Food and Drug Administration (FDA) has granted its clearance for the Assert-IQ insertable cardiac …


FDA approves Abbott’s rapid portable COVID-19 test

August 27, 2020
Research and Development Abbott, COVID-19, FDA, test

The FDA has given emergency clearance for Abbott’s portable COVID-19 test that it will sell for just $5.  The company’s …

Abbott’s COVID-19 test, used at the White House, fails to identify up to 48% of positive cases, study argues

May 15, 2020
Medical Communications, Research and Development Abbott, COVID-19, coronavirus, pharma

Abbott’s 13-minute ID NOW COVID-19 testing kits have come under scrutiny after a study from New York University (NYU) revealed …


FDA approves alternative approach for Abbot HeartMate 3 heart pump

January 8, 2020
Research and Development Abbott, FDA, Heart Pump, US Pharma, heart disease

The FDA announced today that it has approved a new alternative surgical technique for Abbot’s HeartMate 3 heart pump. The …


Abbott CEO to step down after 21 years

November 13, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, appointment

After more than two decades at the head of the company, it has emerged that Miles D White (pictured, right) …


Abbott to boost heart valve therapy portfolio with acquisition of Cephea Valve Technologies

January 17, 2019
Manufacturing and Production, Sales and Marketing Abbott, Cephea, acquistion, mitral valve disease, pharma

As mergers and acquisitions pick up again for the New Year, Abbott has revealed plans to buy medical device firm …


Allergan appoints ex-Abbott exec in “Board refreshment” move

June 15, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, Allergan, appointment, pharma

Allergan has announced another move in its “refreshment” of its executive Board of Directors with the appointment of Thomas C …


Abbott teams up with Angle for metastatic breast cancer study

February 6, 2018
Manufacturing and Production, Research and Development Abbott, Angle, Cancer, breast cancer, pharma

Abbott is set to join forces with liquid biopsy medtech firm Angle to collaborate on a study into metastatic breast …


Novartis, Abbott targeted by Indian watchdog over allegations of price collusion

December 14, 2017
Sales and Marketing Abbott, Emcure Pharma, Galdus, Novartis, USV, diabetes, pharma, vildagliptin

Novartis, Abbott, Emcure Pharma and USV have become the targets of an investigation by the Competition Commission of India (CCI) …


To succeed in emerging market medicine, anticipation and innovation are essential

December 11, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, biotech, drugs, emerging markets, pharma, pharmaceutical

Andrew Lane, Executive Vice President of Established Pharmaceuticals at Abbott, discusses the key steps to be taken when reaching out …


Research into clinical trial transparency shows huge variation in standards

July 28, 2017
Medical Communications, Sales and Marketing Abbott, GSK, biotech, clinical trials, drugs, pharma, pharmaceutical, transparency

A study published in the BMJ displayed the large degree of variation and lack of industry-standard when it comes to …


AbbVie loses $15 million Depakote birth-defect case

June 12, 2017
Sales and Marketing AbbVie, Abbott, Depakote

Court cases for the anti-seizure medicine Depakote continue to rumble on for AbbVie, with the latest case finding AbbVie liable …


26 die after attempting to replace Abbott’s blood pump controller themselves

May 24, 2017
Medical Communications, Sales and Marketing Abbott, FDA, Medical device, deaths

At least 26 advanced heart failure patients have died and 19 have been injured by attempting to change the controller …

Latest content